Related Experiment Video
Updated: Jun 17, 2025
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Evaluating Therapeutic Plasma Exchange in Pediatric Acute Disseminated Encephalomyelitis: A Comprehensive Review
Tanvi Bhardwaj1,2, Sunil Kumar2, Neha Parashar2
1Pathology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Insights
Therapeutic plasma exchange (TPE) shows promise for treating pediatric acute disseminated encephalomyelitis (ADEM). Early intervention with TPE may improve outcomes in severe or refractory cases of this rare autoimmune brain and spinal cord inflammation.
Area of Science:
- Neuroimmunology
- Pediatric Neurology
- Autoimmune Disorders
Background:
- Acute disseminated encephalomyelitis (ADEM) is a rare autoimmune disorder causing brain and spinal cord inflammation.
- Pediatric ADEM poses unique challenges due to rapid progression and potential for long-term neurological deficits.
- Therapeutic plasma exchange (TPE) is being explored for its immunomodulatory effects in autoimmune conditions.
Purpose of the Study:
- To comprehensively review the role of TPE in pediatric ADEM.
- To synthesize evidence on TPE's efficacy, safety, and benefits in children with ADEM.
- To provide insights for clinical practice and future research directions.
Main Methods:
- Systematic review of clinical studies on TPE for pediatric ADEM.
- Analysis of TPE efficacy based on disease severity and patient factors.
- Evaluation of safety profiles and potential adverse events associated with TPE.
Main Results:
- TPE efficacy in pediatric ADEM is variable, influenced by disease severity and individual patient characteristics.
- Early TPE intervention may be beneficial, particularly in severe or treatment-refractory ADEM cases.
- TPE demonstrates a generally acceptable safety profile when managed appropriately.
Conclusions:
- TPE is a viable therapeutic option for pediatric ADEM, especially in severe or refractory presentations.
- Early consideration of TPE is crucial for potentially mitigating long-term neurological sequelae.
- Further research, including prospective and comparative studies, is needed to optimize TPE protocols and confirm its long-term effectiveness.
Abstract:
Acute disseminated encephalomyelitis (ADEM) is a rare autoimmune disorder characterized by brain and spinal cord inflammation. In pediatric patients, ADEM presents unique challenges due to its potential for rapid progression and long-term neurological sequelae. Therapeutic plasma exchange (TPE) has emerged as a potential treatment option by targeting the underlying autoimmune process and modulating the inflammatory response. This comprehensive review evaluates the role of TPE in pediatric ADEM, synthesizing evidence from clinical studies and providing insights into its efficacy, safety, and potential benefits. The review highlights the variability in TPE efficacy based on disease severity and patient-specific factors. Implications for clinical practice include considering TPE as a therapeutic option, particularly in severe or refractory cases, and emphasizing the importance of early intervention. Recommendations for future research include long-term prospective studies, comparative effectiveness trials, and efforts to standardize TPE protocols. Overall, continued investigation and innovation in managing pediatric ADEM are essential for improving outcomes and quality of life for affected children and their families.
